Form 8-K - Current report:
SEC Accession No. 0001104659-25-065009
Filing Date
2025-07-02
Accepted
2025-07-02 07:05:47
Documents
14
Period of Report
2025-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519514d1_8k.htm   iXBRL 8-K 42812
2 EXHIBIT 99.1 tm2519514d1_ex99-1.htm EX-99.1 15559
6 GRAPHIC image_001.jpg GRAPHIC 5565
  Complete submission text file 0001104659-25-065009.txt   243097

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asth-20250701.xsd EX-101.SCH 3017
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asth-20250701_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asth-20250701_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2519514d1_8k_htm.xml XML 3661
Mailing Address 1668 S. GARFIELD AVENUE 2ND FLOOR ALHAMBRA CA 91801
Business Address 1668 S. GARFIELD AVENUE 2ND FLOOR ALHAMBRA CA 91801 (626) 282-0288
Astrana Health, Inc. (Filer) CIK: 0001083446 (see all company filings)

EIN.: 870042699 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37392 | Film No.: 251098319
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)